[THE INVESTOR] Green Source International of China plans to be listed on KOSDAQ early 2017, and will apply for preliminary investigation in November, according to news reports on Sept. 22.
It will join another Chinese bio company Triplex International Biosciences that hopes to go public in the first quarter of 2017.
Established in 1998, Green Source International is headquartered in Hong Kong, and shifted its focus from fish food manufacturing to health supplement business based on jewel orchid, or Anoectochilus Formosanus, and maca. Its revenue last year reached 67 billion won (US$60.63 million) with net profit of 13 billion won.
The lead counsel for the IPO is Shinhan Investment that is also a consultant for Triplex and Chinese rare herb specialist Fujian Jincao Bioengineering Group, which plans to list later next year.
By Hwang You-mee (
glamazon@heraldcorp.com)
